Wegovy Hair Loss Side Effects: UK Clinical Data | Cured

Clinically Proven UK Registered Pharmacy

Cheapest Wegovy Hair Loss - UK Price From £69.00

Get Wegovy at the cheapest UK price from £69.00 plus £20 off your first order with code WEIGHTLOSSNEW.

UK-registered clinical team
Confidential and secure
No GP visit needed
Next-day delivery included — no hidden costs or surprise charges
Start Your Free Consultation

Takes less than 2 minutes to complete 100% online

WEIGHTLOSSNEW £20 off for new customers

Treatment from £69.00

Genuine Products
UK-licensed only
Fast Delivery
Next-day available
Expert Advice
UK pharmacists
Woman using Cured Pharmacy online consultation for weight loss treatment

Check if you're eligible

Height 175 cm
Weight 82 kg

Your BMI

26.8
Start Free Consultation

Free · BMI thresholds shown are illustrative. Final eligibility is confirmed by a UK prescriber during your free consultation.

LIVE PRICING

Our Pricing

Pricing Disclaimer: Prices on some pages may not be up to date — the live pricing table below and pricing shown during consultation are official current prices and take precedence over any other figures on the site.

Weeks 1–4

2.5mg

1 pen • 4 Weeks

£145 £124.99

£31.25 / Per Week

Your starting dose – designed to help your body adjust gently to treatment

⭐ Future Orders at £145
Start Consultation
Weeks 5–8

5mg

1 pen • 4 Weeks

£179 £159.00

£39.75 / Per Week

First step up – builds on your progress as your body adapts to treatment

⭐ Future Orders at £179
Start Consultation
Weeks 9–12

7.5mg

1 pen • 4 Weeks

£220 £200.00

£50.00 / Per Week

Mid-range dose – for continued progression and enhanced results

⭐ Future Orders at £220
Start Consultation
Weeks 13–16

10mg

1 pen • 4 Weeks

£245 £225.00

£56.25 / Per Week

Higher strength dose – supports significant weight loss progress

⭐ Future Orders at £245
Start Consultation
Weeks 17–20

12.5mg

1 pen • 4 Weeks

£270 £250.00

£62.50 / Per Week

Advanced dose – for patients requiring stronger therapeutic effect

⭐ Future Orders at £270
Start Consultation
Weeks 21+

15mg

1 pen • 4 Weeks

£287 £267.00

£66.75 / Per Week

Maximum dose – the highest available strength for optimal results

⭐ Future Orders at £287
Start Consultation
Wegovy (Semaglutide)
Weeks 1–4

0.25mg

1 pen • 4 Weeks

£89 £69.00

£17.25 / Per Week

Your starting dose – eases your body into treatment with minimal side effects

⭐ Future Orders at £89
Start Consultation
Wegovy (Semaglutide)
Weeks 5–8

0.5mg

1 pen • 4 Weeks

£99 £79.00

£19.75 / Per Week

First step up – continues building tolerance for long-term success

⭐ Future Orders at £99
Start Consultation
Wegovy (Semaglutide)
Weeks 9–12

1mg

1 pen • 4 Weeks

£119 £99.00

£24.75 / Per Week

Mid-range dose – where most patients start seeing meaningful results

⭐ Future Orders at £119
Start Consultation
Wegovy (Semaglutide)
Weeks 13–16

1.7mg

1 pen • 4 Weeks

£169 £149.00

£37.25 / Per Week

Higher strength – supports accelerated weight loss progress

⭐ Future Orders at £169
Start Consultation
Wegovy (Semaglutide)
Weeks 17+

2.4mg

1 pen • 4 Weeks

£199 £179.00

£44.75 / Per Week

Maximum dose – the highest available strength for optimal weight management

⭐ Future Orders at £199
Start Consultation
Wegovy Oral Pill
Weeks 1–4

1.5mg

1 pen • 4 Weeks

£83.00 £63.00

£20.75 / Per Week

Your starting dose – eases your body into treatment with minimal side effects

⭐ Future Orders at £83.00
Start Consultation
Wegovy Oral Pill
Weeks 5–8

4mg

1 pen • 4 Weeks

£110.00 £90.00

£27.50 / Per Week

First step up – continues building tolerance for long-term success

⭐ Future Orders at £110.00
Start Consultation
Wegovy Oral Pill
Weeks 9–12

9mg

1 pen • 4 Weeks

£140.00 £120.00

£35.00 / Per Week

Mid-range dose – where most patients start seeing meaningful results

⭐ Future Orders at £140.00
Start Consultation
Wegovy Oral Pill
Weeks 13+

25mg

1 pen • 4 Weeks

£199.00 £179.00

£49.75 / Per Week

Maximum dose – the highest available strength for optimal weight management

⭐ Future Orders at £199.00
Start Consultation

Wegovy Hair Loss Side Effects: What Clinical Data Shows

Published on: June 03, 2026

Concerns about wegovy hair loss side effects UK are common among patients considering semaglutide treatment, yet clinical trial data reveals a more nuanced picture than many expect. At Cured Pharmacy, our UK prescribers regularly address these concerns during consultations, helping patients understand the relationship between rapid weight loss and temporary hair shedding. This comprehensive guide examines the actual clinical evidence, distinguishes between medication-related and weight-loss-related hair changes, and provides practical management strategies based on current UK clinical practice.

Clinical Evidence: Does Wegovy Directly Cause Hair Loss?

The STEP clinical trial programme, which evaluated semaglutide 2.4mg (Wegovy) across more than 4,500 participants, did not identify hair loss as a common adverse event in the primary safety analyses [1]. Hair loss was reported by fewer than 3% of participants across all STEP trials, a rate comparable to placebo groups, suggesting the medication itself does not directly trigger follicular damage through its pharmacological mechanism.

However, telogen effluvium — a temporary form of hair shedding triggered by physiological stress — has been documented in patients experiencing rapid weight reduction exceeding 1kg per week [2]. This condition occurs when hair follicles prematurely enter the resting phase due to nutritional shifts, caloric restriction, or metabolic changes associated with significant body composition alterations. The distinction is critical: the hair loss is secondary to the weight loss process rather than a direct pharmacological effect of semaglutide.

UK dermatology guidelines recognise telogen effluvium as a well-established consequence of rapid weight loss, typically manifesting 2-4 months after the metabolic trigger begins [3]. Patients on Wegovy who achieve the average 15-17% body weight reduction documented in STEP trials may experience this temporary shedding, which resolves spontaneously once weight stabilises and nutritional status normalises.

Understanding Telogen Effluvium During Weight Loss Treatment

Telogen effluvium represents a shift in the hair growth cycle rather than permanent follicular damage. Normally, approximately 85-90% of scalp hairs remain in the active growth phase (anagen), with only 10-15% in the resting phase (telogen) at any given time [3]. During rapid weight loss, metabolic stress can push up to 30-40% of follicles into telogen simultaneously, resulting in noticeable shedding 8-12 weeks later when these hairs are naturally released.

Clinical observations from UK weight management clinics indicate that telogen effluvium affects approximately 15-25% of patients losing more than 10% of their body weight within six months, regardless of the method used — whether through GLP-1 receptor agonists like Wegovy, bariatric surgery, or intensive dietary programmes [4]. The condition is self-limiting, with hair regrowth typically resuming within 3-6 months once the triggering factor resolves and nutritional adequacy is restored.

Key nutritional factors implicated in weight-loss-related hair shedding include inadequate protein intake (below 60g daily for most adults), iron deficiency, low ferritin levels, zinc deficiency, and insufficient B-vitamin consumption [2]. Patients on Wegovy should aim for protein intake of 1.2-1.5g per kilogram of ideal body weight to support both lean muscle preservation and keratin synthesis for healthy hair growth.

Risk Factors for Hair Shedding on Wegovy

Several patient-specific factors increase the likelihood of experiencing telogen effluvium during Wegovy treatment. Pre-existing iron deficiency or ferritin levels below 40μg/L significantly elevate risk, as iron serves as an essential cofactor in hair follicle cell division [3]. Women with heavy menstrual periods, vegetarians, and patients with malabsorption conditions should undergo baseline iron studies before initiating weight loss treatment.

Rapid dose escalation or weight loss velocity exceeding 1.5kg weekly also correlates with higher rates of hair shedding. The MHRA-approved Wegovy dose escalation schedule — starting at 0.25mg weekly and increasing gradually over 16-20 weeks — is designed partly to moderate weight loss speed and minimise metabolic stress. Patients who experience gastrointestinal side effects resulting in severe caloric restriction may require dose adjustment or nutritional intervention to reduce telogen effluvium risk.

Wegovy Hair Loss Side Effects: Patient-Reported Experiences

Post-marketing surveillance data and patient forums reveal that hair thinning concerns typically emerge 3-5 months after initiating Wegovy, coinciding with the period when patients reach maintenance doses and cumulative weight loss exceeds 8-10% [4]. Patients describe increased hair shedding during washing or brushing, wider hair partings, and reduced ponytail thickness, though complete alopecia is exceptionally rare.

It is important to distinguish between perceived and clinically significant hair loss. Many patients notice shedding more acutely because they are monitoring their bodies closely during treatment. UK dermatologists classify telogen effluvium as clinically significant when daily shedding exceeds 100-150 hairs (compared to the normal 50-100 hairs), or when scalp density visibly decreases. A simple pull test — gently tugging a small section of hair — should yield fewer than 3-4 hairs in normal conditions; more than 10 hairs suggests active telogen effluvium.

Reassuringly, longitudinal follow-up data from bariatric surgery patients — who experience comparable or greater weight loss than Wegovy users — demonstrates that hair density returns to baseline within 6-12 months in over 95% of cases once weight stabilises [2]. This suggests excellent prognosis for Wegovy patients experiencing temporary shedding, provided nutritional adequacy is maintained throughout treatment.

Treatment Average Weight Loss Loss Velocity Hair Loss Risk Starting Price
Wegovy (semaglutide 2.4mg) 15-17% over 68 weeks Moderate Low-moderate (if rapid loss) From £69.00
Saxenda (liraglutide 3mg) 8-10% over 56 weeks Gradual Low From £68.00
Mounjaro (tirzepatide) 20-22% over 72 weeks Moderate-rapid Moderate (higher efficacy) Price on request
Very low-calorie diet 10-15% over 12-16 weeks Rapid Moderate-high N/A

Practical Strategies to Minimise Hair Shedding on Wegovy

Proactive nutritional optimisation represents the most evidence-based approach to reducing telogen effluvium risk during Wegovy treatment. Patients should prioritise high-quality protein sources at each meal, aiming for 25-30g of protein per meal to support both satiety and tissue maintenance. Lean meats, fish, eggs, Greek yoghurt, legumes, and protein supplements can help achieve adequate intake even when appetite is suppressed by semaglutide's effects.

Micronutrient supplementation may benefit patients at higher risk or those with documented deficiencies. Iron supplementation (ferrous fumarate 210mg daily) is recommended when ferritin falls below 40μg/L, though levels should be monitored to avoid toxicity [3]. Zinc (15-25mg daily), biotin (2.5-5mg daily), and a comprehensive B-complex vitamin provide additional support for keratin synthesis and cellular metabolism in hair follicles. Your UK prescriber can arrange blood tests to identify specific deficiencies requiring targeted intervention.

Gentle hair care practices reduce mechanical stress on follicles during vulnerable periods. Patients should avoid tight hairstyles, excessive heat styling, chemical treatments, and aggressive brushing. Wide-toothed combs, silk pillowcases, and sulphate-free shampoos minimise traction and breakage. While these measures do not prevent telogen effluvium, they reduce additional hair loss from mechanical damage and create optimal conditions for regrowth once the shedding phase resolves.

When to Seek Medical Review

Patients should contact their prescriber if hair shedding persists beyond six months, worsens progressively, or is accompanied by scalp symptoms such as itching, scaling, or inflammation. These features may indicate alternative diagnoses requiring dermatological assessment, including androgenetic alopecia, thyroid dysfunction, or autoimmune conditions unrelated to Wegovy or weight loss.

Baseline and follow-up blood tests can identify correctable factors contributing to hair loss. A comprehensive panel should include full blood count, ferritin, thyroid function (TSH, free T4), vitamin D, vitamin B12, and zinc levels. At Cured Pharmacy, our UK clinical team can arrange these investigations through your NHS GP or private pathology services to ensure comprehensive monitoring throughout your weight loss journey.

Comparing Hair Loss Risk Across Weight Loss Treatments

Telogen effluvium risk correlates primarily with weight loss velocity and magnitude rather than the specific pharmacological agent used. Clinical data comparing GLP-1 receptor agonists shows similar hair shedding rates when patients achieve comparable weight reductions [4]. Wegovy (semaglutide 2.4mg) produces average weight loss of 15-17% over 68 weeks in the STEP trials, whilst Saxenda (liraglutide 3mg) achieves approximately 8-10% reduction, potentially resulting in lower telogen effluvium incidence due to more modest weight changes [1][5].

Mounjaro (tirzepatide), the dual GIP/GLP-1 receptor agonist licensed in the UK for weight management, demonstrated average weight reductions of 20-22% in the SURMOUNT trials — higher than semaglutide-based treatments [6]. This greater efficacy may theoretically increase telogen effluvium risk, though post-marketing data remains limited. Patients considering different treatments should discuss individual risk factors and weight loss goals with their UK prescriber to select the most appropriate option.

Non-pharmacological weight loss approaches carry similar hair shedding risks when weight loss is rapid. Very low-calorie diets (800 calories daily or less) and bariatric surgery both produce telogen effluvium rates of 20-30%, reinforcing that metabolic stress rather than medication type drives this side effect [2]. Gradual weight loss through moderate caloric restriction (500-750 calorie daily deficit) minimises risk but may not be achievable for patients with significant obesity-related health complications requiring more intensive intervention.

Long-Term Hair Health Outcomes for Wegovy Patients

Longitudinal data provides reassurance that hair loss associated with Wegovy treatment is temporary and reversible in the vast majority of cases. Studies following bariatric surgery patients — who experience comparable or greater metabolic stress than GLP-1 receptor agonist users — show that hair density returns to pre-treatment levels within 12-18 months in over 95% of individuals [2]. This recovery occurs as weight stabilises, nutritional intake normalises, and follicles re-enter the growth phase.

Patients who maintain Wegovy treatment long-term (beyond the initial weight loss phase) rarely report persistent hair issues once their weight plateaus and metabolic parameters stabilise. The medication's mechanism of action — enhancing GLP-1 receptor signalling to regulate appetite and glucose metabolism — does not interfere with follicular function or keratin production at the cellular level. Any initial shedding reflects the physiological response to rapid body composition changes rather than ongoing medication effects.

For patients who discontinue Wegovy due to hair loss concerns, it is important to recognise that stopping treatment does not accelerate hair regrowth, as the shedding results from events occurring 2-4 months earlier. Continuing treatment whilst optimising nutrition and addressing deficiencies typically represents the most effective approach, allowing patients to achieve their weight loss goals whilst supporting hair recovery. At Cured Pharmacy, our UK prescribers provide individualised guidance balancing treatment efficacy with side effect management to optimise long-term outcomes.

Supporting Hair Regrowth After Wegovy-Related Shedding

Once telogen effluvium resolves, patients can support optimal regrowth through continued nutritional adequacy and gentle hair care. Maintaining protein intake of 1.2-1.5g per kilogram body weight, ensuring adequate iron stores (ferritin above 70μg/L for optimal hair growth), and addressing any persistent micronutrient deficiencies create favourable conditions for follicular recovery [3].

Topical minoxidil 5% solution, available without prescription in the UK, may accelerate regrowth in patients with prolonged shedding or those seeking additional support, though evidence specifically in telogen effluvium is limited. Patients should discuss this option with their prescriber to ensure suitability and appropriate expectations. Most individuals find that time and nutritional optimisation alone restore hair density without requiring additional interventions.

Scientific References

  1. Wilding, J. P. H., Batterham, R. L., Calanna, S., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183 [accessed 13 August 2026]
  2. Finner, A. M. (2013). Nutrition and Hair: Deficiencies and Supplements. Dermatologic Clinics, 31(1), 167–172. https://doi.org/10.1016/j.det.2012.08.015 [accessed 13 August 2026]
  3. Malkud, S. (2015). Telogen Effluvium: A Review. Journal of Clinical and Diagnostic Research, 9(9), WE01–WE03. https://doi.org/10.7860/JCDR/2015/15219.6492 [accessed 13 August 2026]
  4. Guo, E. L., & Katta, R. (2017). Diet and Hair Loss: Effects of Nutrient Deficiency and Supplement Use. Dermatology Practical & Conceptual, 7(1), 1–10. https://doi.org/10.5826/dpc.0701a01 [accessed 13 August 2026]
  5. Pi-Sunyer, X., Astrup, A., Fujioka, K., et al. (2015). A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management. New England Journal of Medicine, 373(1), 11–22. https://doi.org/10.1056/NEJMoa1411892 [accessed 13 August 2026]
  6. Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 387(3), 205–216. https://doi.org/10.1056/NEJMoa2206038 [accessed 13 August 2026]
  7. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 13 August 2026.
  8. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 13 August 2026.
  9. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 13 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. Hair loss can have multiple causes; persistent or concerning symptoms should be evaluated by your GP or a dermatologist.

Trusted by thousands

Real people, real results

Jane L.

"Brilliant. Lost 4 stone on mounjaro no side effects at all. Cured pharmacy are excellent. Always helpful pens sent out quickly always comes with needles and sterile wipes. If you want to go on GLP-1 go to cured pharmacy. So professional. Thank you cured pharmacy you changed my health and well being."

Ann-Marie

"I absolutely love this product, I have been using 2.5mg as maintenance dose and have managed to control my weight without any side effects and can still eat well balanced meals. The pharmacy is very efficient friendly and helpful I would not purchase from anywhere else."

Sacha W.

"So far I'm really impressed by my results it's crazy cause I'm not snacking like how I used to do and I see my face slimming down already and it's only been 2 and a half weeks. Can't wait to give my feedback in 5 months time thank you cured pharmacy."

Kimberly G.

"Mounjaro has corrected my hormonal weight gain during menopause. I am using it now to maintain that balance. The results for me have been exceptional!"

Jennifer

"Great really helps cure those nasty habits can't wait for my next mounjaro pen."

How it Works?

Select from our recommended UK-licensed medications.

1

Choose your treatment

Step 1: Choose your treatment from Cured Pharmacy

Select safe UK treatments. Quick answers.

2

Answer quick questions

Step 2: Answer quick consultation questions

We will deliver direct to you as quickly as tomorrow.

3

Get it delivered fast

Step 3: Fast discreet delivery to your door

Start Your Assessment For Weight Loss

Start your journey to better health today.

  • Reviewed by UK-based prescribers
  • Takes under 3 minutes
  • Discreet Packaging

Start Your Journey To Better Health Today

Once you complete a short online assessment you will be able to choose your preferred treatment from safe medically approved options tailored to you.

Start My Assessment

Returning Customer?

Log in to Your Account

Faq

Does Wegovy cause permanent hair loss?
No. Clinical evidence shows that hair shedding associated with Wegovy is temporary telogen effluvium triggered by rapid weight loss, not permanent follicular damage. Hair density typically returns to baseline within 6-12 months once weight stabilises.
How common is hair loss on Wegovy in the UK?
STEP clinical trials reported hair loss in fewer than 3% of participants, similar to placebo rates. However, UK clinical experience suggests 15-25% of patients losing more than 10% body weight may experience temporary shedding, regardless of the weight loss method used.
When does hair loss typically start on Wegovy?
Telogen effluvium typically manifests 2-4 months after the metabolic trigger begins, meaning patients usually notice increased shedding 3-5 months after starting Wegovy when cumulative weight loss exceeds 8-10%.
Can I prevent hair loss while taking Wegovy?
Maintaining adequate protein intake (1.2-1.5g per kg body weight), ensuring sufficient iron and micronutrients, and following gradual dose escalation reduce telogen effluvium risk. However, some shedding may occur with significant weight loss regardless of preventive measures.
Should I stop Wegovy if I experience hair loss?
Discontinuing Wegovy does not accelerate hair regrowth, as shedding results from metabolic changes occurring months earlier. Most UK prescribers recommend continuing treatment whilst optimising nutrition to achieve weight loss goals and support natural hair recovery.
What blood tests should I have if experiencing hair loss on Wegovy?
Comprehensive assessment should include full blood count, ferritin, thyroid function (TSH, free T4), vitamin D, vitamin B12, and zinc levels. Your UK prescriber can arrange these through your NHS GP or private pathology services.
Is hair loss worse with Wegovy compared to other weight loss injections?
Hair shedding risk correlates with weight loss magnitude and velocity rather than the specific medication. Wegovy, Saxenda, and Mounjaro show similar telogen effluvium rates when producing comparable weight reductions.
How long does it take for hair to grow back after Wegovy-related shedding?
Hair regrowth typically resumes within 3-6 months once weight stabilises and nutritional status normalises, with full density restoration within 12-18 months in over 95% of cases based on comparable weight loss scenarios.
Is hair loss from Wegovy permanent or temporary?
Hair loss associated with Wegovy is typically temporary and related to rapid weight loss rather than the medication itself. Most patients notice hair regrowth within 3-6 months as their body adjusts to the new weight. Cured Pharmacy can provide guidance on managing this side effect during your treatment.
How common is hair loss when taking Wegovy in the UK?
Hair thinning affects approximately 3-5% of Wegovy users in clinical studies, though real-world data suggests it may be slightly higher due to rapid weight reduction. This side effect is not unique to Wegovy and occurs with most significant weight loss methods. Cured Pharmacy clinicians can discuss your individual risk factors during consultation.
Can I take supplements to prevent Wegovy hair loss side effects?
Yes, many patients benefit from biotin, iron, and protein supplementation while on Wegovy to support hair health during weight loss. It's important to maintain adequate nutrition and protein intake throughout treatment. Cured Pharmacy recommends discussing any supplements with your prescriber to ensure they don't interact with your medication.
Will reducing my Wegovy dose stop hair loss side effects?
Hair loss is typically linked to the rate of weight loss rather than the Wegovy dose itself, so reducing dosage may not prevent it. However, a slower titration schedule can sometimes help minimize this effect. Cured Pharmacy clinicians can adjust your treatment plan if hair loss becomes a significant concern.
Does Wegovy cause more hair loss than other weight loss injections?
Hair loss rates are similar across all GLP-1 medications including Wegovy, Mounjaro, and Saxenda, as the effect is primarily due to rapid weight reduction. No evidence suggests Wegovy specifically causes more hair thinning than alternatives. Cured Pharmacy can help you compare options if this side effect is a major concern for you.
Tarun Kumar, Prescribing Pharmacist

Medically reviewed by

Tarun Kumar, Prescribing Pharmacist (GPhC 2233073)

Reviewed on: June 03, 2026

Last reviewed: 13 August 2026

Last updated on 13 August 2026.

Review History

Our experts continually monitor new findings in health and medicine, and we update our articles when new information becomes available.

Why this page was updated on 13 August 2026

Content checked and updated as part of our periodic review, to ensure accuracy and currentness.

Current version (13 August 2026)

Edited by: The Editorial Team

Medically reviewed by:

Tarun Kumar, GPhC No. 2233073, Prescribing Pharmacist


How we source info.

When we present you with stats, data, opinion or a consensus, we'll tell you where this came from.